Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Substance Name: Dronabinol
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: The particular context of virus infection.
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
RNF and Betaseron® Tolerability Study (REFORMS)
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients.
Transcriptional enhancers: from properties to genome-wide predictions.
Recent Gains in Clinical Multiple Sclerosis Research Review.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.

Pages